Phase 2 head-to-head (COMPARE) clinical trial of SEL-212 vs. KRYSTEXXA® to begin in 1Q19,
interim six-month data expected in 4Q19
Collaboration with CureCN projected to dose first patient with combination of ImmTOR + AAV
gene therapy candidate in 2H19
Company raises $33M in gross offering proceeds and $31.3M in net proceeds in 1Q19, cash
runway into 1Q20...
Formed a nice bottom. Looks like a cup and handle pattern is forming. I could see it spiking to $5. has not taken the 50EMA yet so I wouldn't put in a buy order. Of course it means missing some gains, but playing it safe is never a bad idea. Always more opportunities
As you can tell, SELB price action dropped to all time lows, but now five insider's are buy stocks. Not optionable, but you can buy stock at this time. I would be looking by EOY a price action of around $14.71 to $15.00. When I am buying an stock or option and/or both-- like to be on same buy train with insiders. As, always do further research in any stocks that...